260 related articles for article (PubMed ID: 33155341)
1. Neoantigen prediction in human breast cancer using RNA sequencing data.
Hashimoto S; Noguchi E; Bando H; Miyadera H; Morii W; Nakamura T; Hara H
Cancer Sci; 2021 Jan; 112(1):465-475. PubMed ID: 33155341
[TBL] [Abstract][Full Text] [Related]
2. Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole-exome sequencing.
Karasaki T; Nagayama K; Kuwano H; Nitadori JI; Sato M; Anraku M; Hosoi A; Matsushita H; Takazawa M; Ohara O; Nakajima J; Kakimi K
Cancer Sci; 2017 Feb; 108(2):170-177. PubMed ID: 27960040
[TBL] [Abstract][Full Text] [Related]
3. Inconsistency and features of single nucleotide variants detected in whole exome sequencing versus transcriptome sequencing: A case study in lung cancer.
O'Brien TD; Jia P; Xia J; Saxena U; Jin H; Vuong H; Kim P; Wang Q; Aryee MJ; Mino-Kenudson M; Engelman JA; Le LP; Iafrate AJ; Heist RS; Pao W; Zhao Z
Methods; 2015 Jul; 83():118-27. PubMed ID: 25913717
[TBL] [Abstract][Full Text] [Related]
4. Identification of a neoantigen epitope in a melanoma patient with good response to anti-PD-1 antibody therapy.
Nonomura C; Otsuka M; Kondou R; Iizuka A; Miyata H; Ashizawa T; Sakura N; Yoshikawa S; Kiyohara Y; Ohshima K; Urakami K; Nagashima T; Ohnami S; Kusuhara M; Mitsuya K; Hayashi N; Nakasu Y; Mochizuki T; Yamaguchi K; Akiyama Y
Immunol Lett; 2019 Apr; 208():52-59. PubMed ID: 30880120
[TBL] [Abstract][Full Text] [Related]
5. The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine.
Garofalo A; Sholl L; Reardon B; Taylor-Weiner A; Amin-Mansour A; Miao D; Liu D; Oliver N; MacConaill L; Ducar M; Rojas-Rudilla V; Giannakis M; Ghazani A; Gray S; Janne P; Garber J; Joffe S; Lindeman N; Wagle N; Garraway LA; Van Allen EM
Genome Med; 2016 Jul; 8(1):79. PubMed ID: 27460824
[TBL] [Abstract][Full Text] [Related]
6. Neoantigen-reactive T cells exhibit effective anti-tumor activity against colorectal cancer.
Yu Y; Zhang J; Ni L; Zhu Y; Yu H; Teng Y; Lin L; Xue Z; Xue X; Shen X; Song H; Su X; Sun W; Cai Z
Hum Vaccin Immunother; 2022 Dec; 18(1):1-11. PubMed ID: 33689574
[TBL] [Abstract][Full Text] [Related]
7. Identification of WDFY3 Neoantigens as Prognostic Markers in Longterm Survivors of Extrahepatic Cholangiocarcinoma.
Wang Y; Jin B; Zhou N; Sun Z; Li J; Chen Q; Wu X; Zhou Y; Shi Y; Lu X; Sang X; Mao Y; Du S; Wang W; Bai C
Curr Cancer Drug Targets; 2020; 20(11):875-886. PubMed ID: 32957886
[TBL] [Abstract][Full Text] [Related]
8. Reduced Neoantigen Expression Revealed by Longitudinal Multiomics as a Possible Immune Evasion Mechanism in Glioma.
Nejo T; Matsushita H; Karasaki T; Nomura M; Saito K; Tanaka S; Takayanagi S; Hana T; Takahashi S; Kitagawa Y; Koike T; Kobayashi Y; Nagae G; Yamamoto S; Ueda H; Tatsuno K; Narita Y; Nagane M; Ueki K; Nishikawa R; Aburatani H; Mukasa A; Saito N; Kakimi K
Cancer Immunol Res; 2019 Jul; 7(7):1148-1161. PubMed ID: 31088845
[TBL] [Abstract][Full Text] [Related]
9. Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment.
Fehlings M; Jhunjhunwala S; Kowanetz M; O'Gorman WE; Hegde PS; Sumatoh H; Lee BH; Nardin A; Becht E; Flynn S; Ballinger M; Newell EW; Yadav M
J Immunother Cancer; 2019 Sep; 7(1):249. PubMed ID: 31511069
[TBL] [Abstract][Full Text] [Related]
10. Limitations of Detecting Genetic Variants from the RNA Sequencing Data in Tissue and Fine-Needle Aspiration Samples.
Kaya C; Dorsaint P; Mercurio S; Campbell AM; Eng KW; Nikiforova MN; Elemento O; Nikiforov YE; Sboner A
Thyroid; 2021 Apr; 31(4):589-595. PubMed ID: 32948110
[No Abstract] [Full Text] [Related]
11. Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations.
Oberg JA; Glade Bender JL; Sulis ML; Pendrick D; Sireci AN; Hsiao SJ; Turk AT; Dela Cruz FS; Hibshoosh H; Remotti H; Zylber RJ; Pang J; Diolaiti D; Koval C; Andrews SJ; Garvin JH; Yamashiro DJ; Chung WK; Emerson SG; Nagy PL; Mansukhani MM; Kung AL
Genome Med; 2016 Dec; 8(1):133. PubMed ID: 28007021
[TBL] [Abstract][Full Text] [Related]
12. Mitochondria sequence mapping strategies and practicability of mitochondria variant detection from exome and RNA sequencing data.
Zhang P; Samuels DC; Lehmann B; Stricker T; Pietenpol J; Shyr Y; Guo Y
Brief Bioinform; 2016 Mar; 17(2):224-32. PubMed ID: 26249222
[TBL] [Abstract][Full Text] [Related]
13. Reliable Analysis of Clinical Tumor-Only Whole-Exome Sequencing Data.
Oh S; Geistlinger L; Ramos M; Morgan M; Waldron L; Riester M
JCO Clin Cancer Inform; 2020 Apr; 4():321-335. PubMed ID: 32282230
[TBL] [Abstract][Full Text] [Related]
14. Using RNA-Seq Data for the Detection of a Panel of Clinically Relevant Mutations.
Wolff A; Perera-Bel J; Schildhaus HU; Homayounfar K; Schatlo B; Bleckmann A; Beißbarth T
Stud Health Technol Inform; 2018; 253():217-221. PubMed ID: 30147077
[TBL] [Abstract][Full Text] [Related]
15. Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies.
Lo AA; Wallace A; Oreper D; Lounsbury N; Havnar C; Pechuan-Jorge X; Wu TD; Bourgon R; Jones R; Krogh K; Yang GY; Zill OA
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599029
[TBL] [Abstract][Full Text] [Related]
16. Integrated RNA and DNA sequencing improves mutation detection in low purity tumors.
Wilkerson MD; Cabanski CR; Sun W; Hoadley KA; Walter V; Mose LE; Troester MA; Hammerman PS; Parker JS; Perou CM; Hayes DN
Nucleic Acids Res; 2014 Jul; 42(13):e107. PubMed ID: 24970867
[TBL] [Abstract][Full Text] [Related]
17. Applications of Next-Generation Sequencing in Neoantigen Prediction and Cancer Vaccine Development.
Lancaster EM; Jablons D; Kratz JR
Genet Test Mol Biomarkers; 2020 Feb; 24(2):59-66. PubMed ID: 30907630
[TBL] [Abstract][Full Text] [Related]
18. Neoantigen landscape in metastatic nasopharyngeal carcinoma.
Lin M; Zhang XL; You R; Yang Q; Zou X; Yu K; Liu YP; Zou RH; Hua YJ; Huang PY; Wang J; Zhao Q; Jiang XB; Tang J; Gu YK; Yu T; He GP; Xie YL; Wang ZQ; Liu T; Chen SY; Zuo ZX; Chen MY
Theranostics; 2021; 11(13):6427-6444. PubMed ID: 33995666
[No Abstract] [Full Text] [Related]
19. Modeling clonal structure over narrow time frames via circulating tumor DNA in metastatic breast cancer.
Weber ZT; Collier KA; Tallman D; Forman J; Shukla S; Asad S; Rhoades J; Freeman S; Parsons HA; Williams NO; Barroso-Sousa R; Stover EH; Mahdi H; Cibulskis C; Lennon NJ; Ha G; Adalsteinsson VA; Tolaney SM; Stover DG
Genome Med; 2021 May; 13(1):89. PubMed ID: 34016182
[TBL] [Abstract][Full Text] [Related]
20. The eSNV-detect: a computational system to identify expressed single nucleotide variants from transcriptome sequencing data.
Tang X; Baheti S; Shameer K; Thompson KJ; Wills Q; Niu N; Holcomb IN; Boutet SC; Ramakrishnan R; Kachergus JM; Kocher JP; Weinshilboum RM; Wang L; Thompson EA; Kalari KR
Nucleic Acids Res; 2014 Dec; 42(22):e172. PubMed ID: 25352556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
